For the Inventor, By the Inventor

Enter assignee name

Tarrytown, NY, United States of America

Regeneron Pharmaceuticals, Inc.

USPTO Granted Patents = 1,345

CIPO Patents = 64

EPO Patents = 442

Trademarks = 78

Forward Citations = 12,199

Loading Chart...

Loading Chart...

836 inventors (with patents filed for the assignee):

Andrew J Murphy (327 out of 349 patents)

George D Yancopoulos (191 out of 200 patents)

Lynn Macdonald (171 out of 180 patents)

4. Sean Stevens (152 out of 158 patents)

5. Cagan Gurer (94 out of 96 patents)

6. Nicholas J Papadopoulos (89 out of 92 patents)

7. David M Valenzuela (88 out of 92 patents)

8. Gavin Thurston (70 out of 74 patents)

9. Gang Chen (69 out of 70 patents)

10. James P Fandl (63 out of 64 patents)

11. Samuel H Davis (62 out of 67 patents)

12. Joel H Martin (57 out of 59 patents)

13. Eric L Smith (56 out of 85 patents)

14. David Frendewey (54 out of 56 patents)

15. William C Olson (53 out of 83 patents)

Core Competencies:

Viral Capsid Proteins

High Affinity Antibodies

Protein Complex Characterization

Genome Modification

Bispecific Antibodies

Drug Product Impurities

CRISPR/Cas Screening

Therapeutic Monoclonal Antibodies

Adoptive Cellular Therapy

Gene-Editing Systems

Humanized Mice Models

Immunotherapy Approaches

1,345 patents: Sort by Forward Citations

1. 12510521 - Devices and systems for chromatography column bed support management and related methods (2025-12-30),

2. 12509687 - Treatment of decreased bone mineral density with zinc and ring finger 3 (ZNRF3) inhibitors (2025-12-30),

3. 12496470 - Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments (2025-12-16),

4. 12480947 - Method for generating high affinity antibodies (2025-11-25),

5. 12480139 - Methods for analysis of viral capsid protein composition (2025-11-25),

6. 12474349 - Methods for characterizing protein complexes (2025-11-18),

7. 12473574 - Methods for modifying a genome (2025-11-18),

8. 12460270 - Systems and methods for identifying viral contaminants (2025-11-04),

9. 12459991 - Compositions and methods for using bispecific antibodies to bind complement and a target antigen (2025-11-04),

10. 12459986 - System and method for characterizing drug product impurities (2025-11-04),

11. 12458746 - Medical device packaging and related methods (2025-11-04),

12. 12454580 - FRB antibodies (2025-10-28),

13. 12449198 - Target residual moisture content for lyophilized drug product (2025-10-21),

14. 12448435 - Anti-TMPRSS6 antibodies and uses thereof (2025-10-21),

15. 12441800 - Bispecific anti-PSMA x anti-CD28 antibodies and uses thereof (2025-10-14),

Regeneron Pharmaceuticals, Inc. is a leading biotechnology company revolutionizing the treatment of serious diseases through innovative science. The company creates and manufactures medicines and therapies for conditions such as inflammation, oncology, and metabolic diseases. Regeneron is committed to transforming lives by constantly pushing the boundaries of scientific research and fostering partnerships for the development of life-saving drugs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

1,345 Patents

#2 in Tarrytown, NY

#22 in New York

#366 in US

#717 in the World

Tarrytown, NY, United States of America

Regeneron Pharmaceuticals, Inc.

Forward Citations = 12,199

836 inventors:

Andrew J Murphy (327 out of 349 patents)

George D Yancopoulos (191 out of 200 patents)

Lynn Macdonald (171 out of 180 patents)

4. Sean Stevens (152 out of 158 patents)

5. Cagan Gurer (94 out of 96 patents)

Please report any incorrect information to support@idiyas.com

Loading…